Form 4: Teva Pharmaceutical Executive VP Richard Daniell Reports Share Sales and RSU Vesting
SEC Form 4
Executive VP Richard Daniell reports the vesting of restricted share units (RSUs) and subsequent sale of shares to cover tax obligations, alongside sales under a pre-arranged 10b5-1 trading plan.
Summary
- Richard Daniell, Executive VP of European Commercial at Teva Pharmaceutical Industries Ltd, filed a Form 4 detailing changes in beneficial ownership.
- On March 5, 2024, Daniell vested 22,576 restricted share units (RSUs) granted on March 5, 2021, and 55,226 RSUs granted on January 30, 2024.
- Following the vesting, Daniell sold 22,576 shares at a weighted average price of $13.5154, ranging from $13.41 to $13.61, and 26,053 shares to cover tax withholding obligations.
- These transactions were executed under a Rule 10b5-1 trading plan adopted on November 13, 2023.
- After these transactions, Daniell directly owns 98,943 ordinary shares.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The filing reflects routine transactions related to executive compensation and pre-planned share sales. There is no indication of unusual or concerning activity.
Positives
- The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a planned and orderly approach to share sales.
Industry Context
Form 4 filings are routine disclosures for corporate insiders and provide transparency into their trading activities. Vesting of RSUs is a common form of executive compensation in the pharmaceutical industry.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the sale of shares by an executive, but the pre-planned nature of the sales mitigates concerns.
Key Dates
| Date | Description |
|---|---|
| 2021-03-05 | Restricted share units were granted on March 5, 2021, with 22,576 vesting on each of March 5, 2022, March 5, 2023, March 5, 2024 and March 5, 2025. |
| 2023-11-13 | Rule 10b5-1 trading plan adopted by the reporting person on November 13, 2023. |
| 2024-01-30 | Restricted share units were granted on January 30, 2024 pursuant to the satisfaction of performance criteria and vested on March 5, 2024. |
| 2024-03-05 | Earliest transaction date: vesting of restricted share units and sale of shares. |
| 2024-03-07 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.